Abstract
Hereditary breast (BC), ovarian (OC) and pancreatic (PC) cancers are the major BRCA-associated tumours. However, some BRCA1/2-non informative patients with a strong cancer personal and/or family history need a further genetic testing through a multi-gene panel including other high- and moderate-risk susceptibility genes. In recent years, Next-Generation Sequencing has allowed to study multiple genes simultaneously, reducing analysis costs, increasing genetic data, and offering more information to patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
